NY-JEFFERIES-FINANCIAL
28.5.2020 18:04:07 CEST | Business Wire | Press release
Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.
Through the firm’s Global Coronavirus Relief Charity Day held May 27th, Jefferies’ clients helped to generate $7.65 million in donated net trading commissions. In addition, Jefferies as a firm will donate $1 million directly, and voluntary donations from Jefferies’ 3,822 employees totaled $600,000.
“We could not be prouder of our entire Jefferies family for raising $9.25 million and are greatly appreciative of the incredible partnership our clients have shown us in supporting our fight against Covid-19. The full $9.25 million will be wired today and go to direct relief efforts at over 85 worthy global charities who are each in the front lines helping those most impacted by the Coronavirus global pandemic. We went broadly to a large number of charities globally as this is truly a tragedy that affects all of us and, in particular, those who are most disadvantaged and in the greatest need.
The charities selected are both big and small and represent everything from food banks, child care services, assistance with PPE and other medical supplies, support for front line medical workers, assistance for afflicted military personnel, local teen centers, support for police and fire, workforce training and re-training and many other worthy areas that are most in need. We thank our employees and clients for aiding in the selection of many of these remarkable charities.
Finally, all of us at Jefferies would like to thank all the dedicated professionals working tirelessly on the front line to help those in need. They are the true heroes whom we are honored to help in Peg’s name.”
Contributions in the following amounts will be immediately distributed to these respected organizations:
NYC Mayor’s Fund | Peg’s Cure |
|
$ 150,000 |
All Hands and Hearts |
|
$ 150,000 |
American Heart Association |
$ 150,000 |
|
Bowery Mission |
$ 150,000 |
|
Hackensack Meridian Health Foundation |
$ 150,000 |
|
Houston Police Foundation |
|
$ 150,000 |
International Rescue Committee |
|
$ 150,000 |
Robin Hood Foundation |
|
$ 150,000 |
Strive |
|
$ 150,000 |
The Bass Foundation |
|
$ 150,000 |
World Central Kitchen |
|
$ 150,000 |
We Can #TogetherFromHome |
|
$ 100,000 |
Achievement First |
|
$ 100,000 |
Aktion Deutschland Hilft |
|
$ 100,000 |
Alzheimer’s Association |
|
$ 100,000 |
Ambitious About Autism |
|
$ 100,000 |
Barnardo’s |
$ 100,000 |
|
BMS Family Health and Wellness Center |
|
$ 100,000 |
Bob Woodruff Foundation |
|
$ 100,000 |
Boys & Girls Clubs of the Austin Area |
|
$ 100,000 |
Brewers Community Foundation |
|
$ 100,000 |
Buttle UK |
|
$ 100,000 |
Central Texas Food Bank |
|
$ 100,000 |
Chelsea and Westminster Hospital NHS Foundation Trust |
|
$ 100,000 |
Chrysalis |
$ 100,000 |
|
City Harvest |
$ 100,000 |
|
Citymeals on Wheels |
|
$ 100,000 |
Columbia Children's Hospital |
|
$ 100,000 |
Community Food Bank of New Jersey |
|
$ 100,000 |
Covenant House |
|
$ 100,000 |
Doctors Without Borders |
|
$ 100,000 |
East High – EOP (Education Partnership Organization) |
|
$ 100,000 |
Elmhurst Hospital Charity |
|
$ 100,000 |
Family Promise of Bergen County |
|
$ 100,000 |
FarmLink |
|
$ 100,000 |
Feeding America |
|
$ 100,000 |
Food Bank For New York City |
|
$ 100,000 |
Foodlink |
|
$ 100,000 |
Habitat for Humanity Japan |
|
$ 100,000 |
Hance Family Foundation |
|
$ 100,000 |
Humanity & Inclusion |
|
$ 100,000 |
Hunger Free America |
|
$ 100,000 |
Imperial Health Charity |
|
$ 100,000 |
Kids in Crisis |
|
$ 100,000 |
Kohka Foundation |
|
$ 100,000 |
Lahey Clinic Foundation |
|
$ 100,000 |
Mail Force Charity |
|
$ 100,000 |
Martha’s Table |
|
$ 100,000 |
Médecins Sans Frontières |
|
$ 100,000 |
Memorial Hermann Foundation |
|
$ 100,000 |
My Sister's Place |
|
$ 100,000 |
National Emergencies Trust |
|
$ 100,000 |
Navajo Nation Covid-19 Relief Fund |
|
$ 100,000 |
Nazareth Housing |
|
$ 100,000 |
Neighbourly Community Fund |
|
$ 100,000 |
NHS Charities Together |
|
$ 100,000 |
Northwell Health's COVID-19 Emergency Fund |
|
$ 100,000 |
NYU Langone |
|
$ 100,000 |
Off Their Plate |
|
$ 100,000 |
Oxfam India |
|
$ 100,000 |
Philippine Disaster Resilience Foundation |
|
$ 100,000 |
Red Hook Initiative |
|
$ 100,000 |
Rosetree Trust |
|
$ 100,000 |
Royal College of Nursing Foundation |
|
$ 100,000 |
RVNAhealth |
|
$ 100,000 |
Second Harvest |
|
$ 100,000 |
Sempre Con Voi (Always with You) |
|
$ 100,000 |
St Michael’s House |
|
$ 100,000 |
TBD 1 |
|
$ 100,000 |
TBD 2 |
|
$ 100,000 |
TBD 3 |
|
$ 100,000 |
TCF Bank |
|
$ 100,000 |
The Care Workers Charity |
|
$ 100,000 |
The River Fund New York |
|
$ 100,000 |
The United Way of Central Indiana COVID-19 Relief Fund |
|
$ 100,000 |
The World Health Organization (WHO) |
|
$ 100,000 |
Trinity's Services & Food for the Homeless |
|
$ 100,000 |
The Trussell Trust |
|
$ 100,000 |
UNICEF |
|
$ 100,000 |
UR Medicine Home Care’s Meals on Wheels |
|
$ 100,000 |
URMC COVID-19 Emergency Fund |
|
$ 100,000 |
Valpo Surf Project, Inc. |
|
$ 100,000 |
Volunteers of Legal Service |
|
$ 100,000 |
Our Dream Their Smile |
|
$ 100,000 |
West Side Campaign Against Hunger |
|
$ 100,000 |
Women United in Philanthropy |
|
$ 100,000 |
Women's Center of Greater Danbury |
|
$ 100,000 |
|
|
|
Jefferies Group LLC is the largest independent, global, full-service investment banking firm headquartered in the U.S. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. Jefferies Group LLC is a wholly owned subsidiary of Jefferies Financial Group Inc. (NYSE: JEF), a diversified financial services company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005663/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
